# Role and Molecular Mechanism of Farnesoid X Receptor(FXR) and RIPK3 in the Formation of Acute Respiratory Distress Syndrome in Neonates

> **NCT02598648** · NA · UNKNOWN · sponsor: **Daping Hospital and the Research Institute of Surgery of the Third Military Medical University** · enrollment: 40 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome
- Acute Lung Injury
- FXR
- RIPK3

## Interventions

- **OTHER:** FXR
- **OTHER:** RIPK3

## Key facts

- **NCT ID:** NCT02598648
- **Lead sponsor:** Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09-20
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02598648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02598648, "Role and Molecular Mechanism of Farnesoid X Receptor(FXR) and RIPK3 in the Formation of Acute Respiratory Distress Syndrome in Neonates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02598648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*